Thalamic Nuclei Volumes in Psychotic Disorders and in Youths With Psychosis Spectrum Symptoms.
Bipolar II Disorder
Bipolar and Related Disorders
Cognition/Learning/Memory
Neuroanatomy
Schizophrenia Spectrum and Other Psychotic Disorders
Journal
The American journal of psychiatry
ISSN: 1535-7228
Titre abrégé: Am J Psychiatry
Pays: United States
ID NLM: 0370512
Informations de publication
Date de publication:
01 12 2020
01 12 2020
Historique:
pubmed:
12
9
2020
medline:
12
1
2021
entrez:
11
9
2020
Statut:
ppublish
Résumé
Thalamus models of psychosis implicate association nuclei in the pathogenesis of psychosis and mechanisms of cognitive impairment. Studies to date have provided conflicting findings for structural deficits specific to these nuclei. The authors sought to characterize thalamic structural abnormalities in psychosis and a neurodevelopmental cohort, and to determine whether nuclear volumes were associated with cognitive function. Thalamic nuclei volumes were tested in a cross-sectional sample of 472 adults (293 with psychosis) and the Philadelphia Neurodevelopmental Cohort (PNC), consisting of 1,393 youths (398 with psychosis spectrum symptoms and 609 with other psychopathologies), using a recently developed, validated method for segmenting thalamic nuclei and complementary voxel-based morphometry. Cognitive function was measured with the Screen for Cognitive Impairment in Psychiatry in the psychosis cohort and the Penn Computerized Neurocognitive Battery in the PNC. The psychosis group had smaller pulvinar, mediodorsal, and, to a lesser extent, ventrolateral nuclei volumes compared with the healthy control group. Youths with psychosis spectrum symptoms also had smaller pulvinar volumes, compared with both typically developing youths and youths with other psychopathologies. Pulvinar volumes were positively correlated with general cognitive function. The study findings demonstrate that smaller thalamic association nuclei represent a neurodevelopmental abnormality associated with psychosis, risk for psychosis in youths, and cognitive impairment. Identifying specific thalamic nuclei abnormalities in psychosis has implications for early detection of psychosis risk and treatment of cognitive impairment in psychosis.
Identifiants
pubmed: 32911995
doi: 10.1176/appi.ajp.2020.19101099
pmc: PMC7708443
mid: NIHMS1624706
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1159-1167Subventions
Organisme : NCATS NIH HHS
ID : UL1 TR000445
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH102266
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001863
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH070560
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH115000
Pays : United States
Organisme : NIMH NIH HHS
ID : K01 MH112774
Pays : United States
Références
Schizophr Res. 2019 May 27;:
pubmed: 31147286
Schizophr Res. 2007 Feb;90(1-3):71-5
pubmed: 17141474
Neurosci Lett. 2006 Jan 9;392(1-2):16-21
pubmed: 16171947
Am J Psychiatry. 2004 Jun;161(6):1016-22
pubmed: 15169689
Can J Psychiatry. 1997 Feb;42(1):27-33
pubmed: 9040920
Am J Psychiatry. 2003 Jun;160(6):1177-9
pubmed: 12777280
Biol Psychiatry. 2009 Jun 15;65(12):1024-31
pubmed: 19251247
PLoS One. 2017 Nov 29;12(11):e0188511
pubmed: 29186161
Schizophr Res. 2019 Aug;210:270-277
pubmed: 30630706
Science. 2012 Aug 10;337(6095):753-6
pubmed: 22879517
Neuroimage. 2014 Nov 15;102 Pt 2:540-7
pubmed: 25139002
Schizophr Bull. 2017 May 1;43(3):601-610
pubmed: 27559077
Schizophr Res. 2017 Feb;180:28-35
pubmed: 27567291
Neuroimage. 2015 Jul 15;115:117-37
pubmed: 25936807
Am J Psychiatry. 2004 Jul;161(7):1270-7
pubmed: 15229061
Front Neurosci. 2018 Feb 06;12:33
pubmed: 29467603
Schizophr Res. 2010 Oct;123(1):1-14
pubmed: 20682456
Arch Gen Psychiatry. 2003 Oct;60(10):983-91
pubmed: 14557143
Am J Psychiatry. 2001 Apr;158(4):618-24
pubmed: 11282698
Mol Psychiatry. 2016 Apr;21(4):547-53
pubmed: 26033243
Neuron. 2011 Jul 28;71(2):209-23
pubmed: 21791281
Schizophr Bull. 1997;23(3):483-501
pubmed: 9327511
Neuron. 2016 Jan 6;89(1):209-20
pubmed: 26748092
Biol Psychiatry. 2018 Mar 15;83(6):509-517
pubmed: 29113642
Behav Brain Res. 2015 Oct 1;292:219-32
pubmed: 26079768
Neuroimage. 1999 Feb;9(2):179-94
pubmed: 9931268
J Neural Transm (Vienna). 2006 Jul;113(7):907-28
pubmed: 16252070
Neuroimage. 2018 Dec;183:314-326
pubmed: 30121337
NPJ Schizophr. 2016 Sep 28;2:16033
pubmed: 27738647
Neuroimage. 2010 Feb 1;49(3):2053-62
pubmed: 19853042
Biol Psychiatry Cogn Neurosci Neuroimaging. 2019 Oct;4(10):859-869
pubmed: 31202821
Hum Brain Mapp. 2018 May;39(5):1995-2006
pubmed: 29380485
Neuron. 2013 Mar 20;77(6):1151-62
pubmed: 23522049
Schizophr Res. 2013 Dec;151(1-3):148-53
pubmed: 24094679
Neuropsychopharmacology. 2018 Feb;43(3):590-597
pubmed: 28895568
Biol Psychiatry. 2005 Jan 1;57(1):83-90
pubmed: 15607304
Neuropsychology. 2012 Mar;26(2):251-265
pubmed: 22251308
J Digit Imaging. 2018 Jun;31(3):304-314
pubmed: 29725960
Neuroimage. 2016 Jan 1;124(Pt B):1097-1101
pubmed: 25988229
Schizophr Res. 2017 Feb;180:58-63
pubmed: 27531067
Mol Psychiatry. 2016 Dec;21(12):1710-1716
pubmed: 26857596
Arch Gen Psychiatry. 2009 Aug;66(8):811-22
pubmed: 19652121
Neuron. 2002 Jan 31;33(3):341-55
pubmed: 11832223
Biol Psychiatry Cogn Neurosci Neuroimaging. 2019 Aug;4(8):706-714
pubmed: 31262708
Biol Psychiatry. 2011 Mar 1;69(5):495-503
pubmed: 21145039
Neuropsychopharmacology. 2019 Aug;44(9):1649-1658
pubmed: 31060043
Arch Gen Psychiatry. 1990 Nov;47(11):1023-8
pubmed: 2241504
Eur Arch Psychiatry Clin Neurosci. 2011 Oct;261(7):467-76
pubmed: 21431919
J Am Acad Child Adolesc Psychiatry. 2019 Nov;58(11):1079-1091
pubmed: 30768396
Am J Psychiatry. 2002 Jan;159(1):59-65
pubmed: 11772691
Schizophr Res. 2017 Feb;180:13-20
pubmed: 27449252
Annu Rev Neurosci. 2018 Jul 8;41:163-183
pubmed: 29618284
Neuron. 2013 Aug 21;79(4):814-28
pubmed: 23972602
Neurosci Biobehav Rev. 2015 Jul;54:57-75
pubmed: 25616183